Cerebral palsy (CP) is the most common physical disability originating in childhood. Approximately 2 of every 1000 babies born acquire this condition that results from abnormal development or damage to the brain. Since CP ...
Sep 13, 2018
0
0
Children's Hospital Los Angeles investigators have demonstrated the need to include a growing constituency of obese and overweight children and adults in clinical research, with their study of a key marker for metabolism ...
Aug 23, 2018
0
12
Investigators at Children's Hospital Los Angeles and the University of Southern California have demonstrated the feasibility of implanting a micropacemaker system in the pericardial sac surrounding the heart—a breakthrough ...
Jun 26, 2018
0
67
Investigators at Children's Hospital Los Angeles have determined that in children receiving gadolinium as a contrast agent to enhance MRI examinations, signal changes attributed solely to deposition of this material in the ...
May 11, 2018
0
22
Investigators at the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles provide preclinical evidence that the presence of tumor-associated macrophages—a type of immune cell—can negatively ...
Apr 24, 2018
0
6
Researchers at Children's Hospital Los Angeles (CHLA) have identified gaps in the United States healthcare system that make it inadequately prepared for the surge in pediatric patients that could result from an infectious ...
Mar 5, 2018
0
3
A study at Children's Hospital Los Angeles is shedding new light on the best therapeutic approach for a rare and aggressive leukemia called mixed phenotype acute leukemia (MPAL).
Feb 27, 2018
0
45
A landmark study published in the Journal of Neuroscience on February 26 reveals that activation of a pregnant mother's immune system can affect her baby's brain development. A team of researchers led by Bradley Peterson, ...
Feb 26, 2018
0
8
Three quarters of patients, both adults and children, with a variety of advanced cancers occurring in different sites of the body responded to larotrectinib, a novel therapy that targets a specific genetic mutation. Results ...
Feb 21, 2018
0
9
Results of the global, multicenter, pivotal phase 2 study that led to the first FDA approval of a gene therapy/cell therapy approach known as CAR T-cell therapy, were published today in the New England Journal of Medicine. ...
Feb 1, 2018
0
255
